EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study)

Anna Agnes Lytzen, Thora Wesenberg Helt iD, Jan Christensen, Thomas Kromann Lund iD, Anna Kalhauge, Frederikke Falkencrone Rönsholt, Daria Podlekavera, Elisabeth Arndal, Anne-Mette Lebech, Birgitte Hanel, Terese L Katzenstein, Ronan M G Berg iD und 1 weitere

Experimental Physiology · 2024

DOI: 10.1113/ep091757 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Experimental Physiology, 2024. Verfasst von Anna Agnes Lytzen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Physical Activity Research, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Diffusing Capacity, Carbon Monoxide, Nitric Oxide. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TrygFonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many patients exhibit persistently reduced pulmonary diffusing capacity after coronavirus disease 2019 (COVID‐19). In this study, dual test gas diffusing capacity for carbon monoxide and nitric oxide ( D L,CO,NO ) metrics and their relationship to disease severity and physical performance were examined in patients who previously had COVID‐19. An initial cohort of 148 patients diagnosed with COVID‐19 of all severities between March 2020 and March 2021 had a D L,CO,NO measurement performed using the single‐breath method at 5.7 months follow‐up. All patients with at least one abnormal D L,CO,NO metric ( n = 87) were revaluated at 12.5 months follow‐up. The D L,CO,NO was used to provide the pulmonary diffusing capacity for nitric oxide ( D L,NO ), the pulmonary diffusing capacity for carbon monoxide ( D L,CO,5s ), the alveolar–capillary membrane diffusing capacity and the pulmonary capillary blood volume. At both 5.7 and 12.5 months, physical performance was assessed using a 30 s sit‐to‐stand test and the 6 min walk test. Approximately 60% of patients exhibited a severity‐dependent decline in at least one D L,CO,NO metric at 5.7 months follow‐up. At 12.5 months, both D L,NO and D L,CO,5s had returned towards normal but still remained abnormal in two‐thirds of the patients. Concurrently, improvements in physical performance were observed, but with no apparent relationship to any D L,CO,NO metric. The severity‐dependent decline in D L,NO and D L,CO observed at 5.7 months after COVID‐19 appears to be reduced consistently at 12.5 months follow‐up in the majority of patients, despite marked improvements in physical performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pulmonary Diffusing CapacityCarbon MonoxideNitric OxideHumansMaleFemaleMiddle AgedProspective StudiesAgedSARS-CoV-2LungAdult

Stichwörter der Autor:innen

SARS‐CoV‐2diffusionlong COVID

Substanzen

Carbon MonoxideNitric Oxide

Autor:innen und Institutionen

  • Centre for Physical Activity Research, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Occupational Therapy and Physiotherapy, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Cardiology, Section for Lung Transplantation, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Radiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Infectious Diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.

ORCID-Profile: Thora Wesenberg Helt, Thomas Kromann Lund, Ronan M G Berg

Förderung

  • TrygFonden

Zitieren

APA

Lytzen, A. A., Helt, T. W., Christensen, J., Lund, T. K., Kalhauge, A., Rönsholt, F. F., Podlekavera, D., Arndal, E., Lebech, A. M., Hanel, B., Katzenstein, T. L., Berg, R. M. G., & Mortensen, J. (2024). Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study). Experimental Physiology. https://doi.org/10.1113/ep091757

Vancouver

Lytzen AA, Helt TW, Christensen J, Lund TK, Kalhauge A, Rönsholt FF, et al. Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study). Experimental Physiology. 2024. doi:10.1113/ep091757

BibTeX
@article{Lytzen2024,
  author = {Lytzen, Anna Agnes and Helt, Thora Wesenberg and Christensen, Jan and Lund, Thomas Kromann and Kalhauge, Anna and Rönsholt, Frederikke Falkencrone and Podlekavera, Daria and Arndal, Elisabeth and Lebech, Anne-Mette and Hanel, Birgitte and Katzenstein, Terese L and Berg, Ronan M G and Mortensen, Jann},
  title = {Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study)},
  journal = {Experimental Physiology},
  year = {2024},
  doi = {10.1113/ep091757}
}
Kostenlos starten →